methylene blue has been researched along with 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brewer, GJ | 1 |
| Hoppel, CL; Ingalls, ST; Kunos, CA; Radivoyevitch, T | 1 |
1 review(s) available for methylene blue and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone
| Article | Year |
|---|---|
Management of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone-induced methemoglobinemia.
Topics: Antidotes; Antineoplastic Agents; Enzyme Inhibitors; Hemoglobins; Humans; Methemoglobin; Methemoglobinemia; Methylene Blue; Pyridines; Ribonucleotide Reductases; Thiosemicarbazones | 2012 |
1 other study(ies) available for methylene blue and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone
| Article | Year |
|---|---|
Rediscovery of the susceptibility of G6PD deficient persons to methemoglobinemia from oxidant drugs, and to hemolysis from methylene blue.
Topics: Enzyme Inhibitors; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Methemoglobinemia; Methylene Blue; Middle Aged; Pyridines; Thiosemicarbazones | 2007 |